Cystoid macular edema after complicated cataract surgery resolved by an intravitreal dexamethasone 0.7-mg implant

Case Reports in Ophthalmology

Volumn 2, Issue 3, 2011, Pages 319-322

  Meyer, Linda M ^a   Schönfeld, Carl Ludwig ^a  

^a Herzog Carl Theodor Eye Clinic   (Germany)

Author keywords

Cystoid macular edema; Dexamethasone 0.7 mg; Irvine Gass syndrome; Ozurdex

Indexed keywords

DEXAMETHASONE;

AGED; ARTICLE; CASE REPORT; CATARACT EXTRACTION; DRUG EFFICACY; DRUG IMPLANT; FEMALE; HUMAN; OFF LABEL DRUG USE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; VISUAL ACUITY;

EID: 84855285706     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000332424     Document Type: Article

References (9)

1. Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L; Pan-American Collaborative Retina Study Group: Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology 2009;116:1481-1487.
2. Drolsum L, Haaskjold E: Causes of decreased visual acuity after cataract extraction. J Cataract Refract Surg 1995;21:59-63.
3. Shelsta HN, Jampol LM: Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina 2011;31:4-12.
4. Sivaprasad S, Bunce C, Wormland R: Non-steroidal anti-inflammatory agents for cystoid macular edema following cataract surgery: a systematic review. Br J Ophthalmol 2005;89:1420-1422. (Pubitemid 41527373)
5. Herrero-Vanell R, Cardillo JA, Kuppermann BD: Clinical applications for the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol 2011;5:139-146.
6. Haller JA, Bandello F, Belfort R Jr, et al.; OZURDEX GENEVA Study Group: Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-1146.
7. Lowder C, Belfort R, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; for the Ozurdex HURON Study Group: Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011;129:545-553.
8. Williams GA, Haller JA, Kuppermann BD, Blumenkranz MS, Weinberg DV, Chou C, Whitcup SM; Dexamethasone DDS Phase II Study group: Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol 2009;147:1048-1054.
9. Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D: Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 2011;52:80-86.